- Home
- SSY vs JAGX Comparison
SSY vs JAGX Comparison
Compare SSY & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- JAGX
- Stock Information
- Founded
- SSY 1959
- JAGX 2013
- Country
- SSY United States
- JAGX United States
- Employees
- SSY N/A
- JAGX N/A
- Industry
- SSY Hospital/Nursing Management
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- SSY Health Care
- JAGX Health Care
- Exchange
- SSY Nasdaq
- JAGX Nasdaq
- Market Cap
- SSY 6.3M
- JAGX 7.4M
- IPO Year
- SSY N/A
- JAGX N/A
- Fundamental
- Price
- SSY $0.83
- JAGX $5.88
- Analyst Decision
- SSY
- JAGX
- Analyst Count
- SSY 0
- JAGX 0
- Target Price
- SSY N/A
- JAGX N/A
- AVG Volume (30 Days)
- SSY 8.5K
- JAGX 247.5K
- Earning Date
- SSY 05-13-2025
- JAGX 05-15-2025
- Dividend Yield
- SSY N/A
- JAGX N/A
- EPS Growth
- SSY N/A
- JAGX N/A
- EPS
- SSY 0.25
- JAGX N/A
- Revenue
- SSY $31,094,000.00
- JAGX $11,689,000.00
- Revenue This Year
- SSY N/A
- JAGX $22.41
- Revenue Next Year
- SSY N/A
- JAGX $30.00
- P/E Ratio
- SSY $3.51
- JAGX N/A
- Revenue Growth
- SSY N/A
- JAGX 19.75
- 52 Week Low
- SSY $0.53
- JAGX $4.02
- 52 Week High
- SSY $1.91
- JAGX $502.50
- Technical
- Relative Strength Index (RSI)
- SSY 40.61
- JAGX 37.09
- Support Level
- SSY $0.82
- JAGX $5.30
- Resistance Level
- SSY $0.87
- JAGX $13.20
- Average True Range (ATR)
- SSY 0.04
- JAGX 1.49
- MACD
- SSY -0.01
- JAGX -0.57
- Stochastic Oscillator
- SSY 3.16
- JAGX 7.30
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.